logo
ScreenersREIT EarningsREIT SectorsMarketplaceLearn
Logo

CollPlant Biotechnologies Ltd.

CLGN

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3Dā€¦ read more

Healthcare

Biotechnology

5 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$2.66

Price

+4.32%

$0.11

$2.55

Previous Close

$2.42

Open

Premium

52w Discount
Market Cap

$30.475m

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$2.472m

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

-$13.866m

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

-$1.22

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

$12.397m

$17.208m

Assets

$4.811m

Liabilities

$2.843m

Debt
Debt to Assets

16.5%

-0.2x

Debt to EBITDA
Free Cash Flow

-$12.417m

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
ā†‘ TopSummaryPriceFinancialsPress Releases
logo
About usFAQ
All the information presented is collected from official and public documents such as: Quarterly and Annual Reports, 10-K (US), Information Form (Canada), Presentations and the Investor Relations (IR) section of the company's website.
The data displayed by alreits.com is solely for informational purposes, we do not recommend the buying, holding or selling of any of the stocks on the website. If you have no experience in the stock market, please talk to your personal licensed investment advisor before making any decisions.